Research and Markets: Diabetic Retinopathy – Pipeline Review, H2 2013

Posted: October 4, 2013 at 4:41 am

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/z9p4jj/diabetic) has announced the addition of the "Diabetic Retinopathy - Pipeline Review, H2 2013" report to their offering.

'Diabetic Retinopathy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Retinopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Retinopathy.

Scope

- A snapshot of the global therapeutic scenario for Diabetic Retinopathy.

- A review of the Diabetic Retinopathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Diabetic Retinopathy pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

Go here to read the rest:
Research and Markets: Diabetic Retinopathy - Pipeline Review, H2 2013

Related Posts

Comments are closed.

Archives